DIGITAL HEALTHCARE

Softhread Announces Successful Completion of a Pilot with the MDEpiNet Coordinating Center at Weill Cornell Medicine

MDEpiNet | December 28, 2021

We are pleased to announce the results of a successful collaboration between MDEpinet-HIVE and Softhread Inc. on a demonstration pilot to highlight the technical feasibility of integrating the Chios™ blockchain platform with the High-performance Integrated Virtual Environment (HIVE), which was conducted in partnership with HIVE system owners. The ecosystem has been built using High-performance Integrated Virtual Environment (HIVE) as provided by DNAHIVE and Blockchain data provenance and smart contract-driven permissioning system as provided by Softhread. The pilot was completed and demoed to the 2021 Temporomandibular Joint Coordinated Registry Network to showcase the first implementation of a patient-driven data registry ecosystem for Temporomandibular Joint Disorders.

"We are thrilled to be part of the MDEpiNet technology vision plan and to work with Softhread technology team on such foundational set of projects that will have a major impact on the way data-driven healthcare is conducted in the future. There is simply no other technology alternative to conducting complex analytics with such a sensitive dataset." 

DNAHIVE's Chief Scientist Dr. Vahan Simonyan

"We are extremely pleased to have demonstrated several of the core capabilities of our Chios™ platform during this pilot, such as pre-built, privacy-preserving smart contracts, advanced access control overlays, support for the publish/subscribe messaging pattern, and integration with off-chain, confidentiality-preserving machine learning models," said Dr. Yelena Yesha, Co-Founder, and Chairwoman of Softhread.

This project is only the first step in highlighting the broader opportunities in leveraging and deploying the capabilities of our technology solutions that would address major pain points in the healthcare and life-sciences industries, as well as become the foundation for Precision Medicine regulatory and compliance efforts.

HIVE is a distributed computing environment used for healthcare technology and biological research. MDEpiNet-HIVE is a technology that provides a secure healthcare biomedical data archival ecosystem. MDEpiNet-HIVE maintains a standardization and harmonization framework, high-performance analytics, and an integrator platform. In addition to the initial HIVE applications to next-generation sequencing, the current universe of HIVE projects covers tailor-made applications involving dimensionality analysis, federated and integrated data mapping, modeling and simulations that apply to basic research, biostatistics, epidemiology, clinical studies, post-market evaluation, manufacturing consistency, environmental metagenomics, outbreak detection, etc.

About MDEpiNet

MDEpiNet is a global Public-Private Partnership, established in 2010, that brings together leadership, expertise, and resources from health care professionals, industry, patient groups, payers, academia, and government to advance a national patient-centered medical device evaluation and surveillance system. The MDEpiNet Coordinating Center at Weill Cornell Medicine supports MDEpiNet operations under a cooperative agreement with the US Food and Drug Administration, Center for Devices and Radiological Health. 

MDEpiNet's mission is to develop and test novel methods, infrastructure, and partnerships for the creation of re-useable real-world data resources and support device evaluation by multiple stakeholders.

In doing so, MDEpiNet collaborates with over 150 partnering organizations, including 120 registries from 45 countries, and has research chapters in the US, Europe, Asia, and Australia. 

About Softhread

Softhread is an information technology company that uses Chios™ - a patent-pending blockchain and AI-enabled platform that preserves confidentiality and optimizes network security while enhancing operational efficiency. Through its decentralized system that empowers state-of-the-art interoperability, Softhread builds scalable enterprise solutions that are highly customizable, industry-agnostic, and optimize the ROI of data management. 

Spotlight

The pumps were run at 999 mL/hr until 50 mL were infused through each set. Then six more samples were collected from each unit and analyzed for plasma hemoglobin, total RBC count, hematocrit and mean corpuscular volume (MCV).


Other News
FUTURE OF HEALTHCARE

Change Healthcare and Optum Extend Merger Agreement

Optum | April 06, 2022

Optum, a diversified health services company, and Change Healthcare a health care technology leader, have agreed to extend their merger agreement to December 31, 2022. “The extended agreement reflects our firm belief in the potential of our combination to improve health care, and in our commitment to contesting the meritless legal challenge to this merger.” In a joint statement, the companies Change Healthcare and Optum share a vision for achieving a simpler, more intelligent and adaptive health system for patients, payers and providers. The combination of Optum and Change Healthcare will connect and simplify the core clinical, administrative and payment processes health care providers and payers depend on to serve patients. Increasing efficiency and reducing friction will benefit the entire health system, resulting in lower costs and a better experience for all stakeholders. Change Healthcare and Optum will detail the benefits of this combination at a two-week trial scheduled to begin on August 1. The U.S. Department of Justice’s attempt to block the combination is without merit and serves only to delay improving the experience and outcomes for all participants in the health system. As part of the extension, Optum will pay a $650 million fee to Change Healthcare in the event the merger is unable to be completed because of the court’s decision. Change Healthcare will pay a special cash dividend of $2.00 per share to its shareholders at or about the time of the closing. About Optum Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 190,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group. About Change Healthcare Change Healthcare is a leading healthcare technology company focused on insights, innovation, and accelerating the transformation of the U.S. healthcare system through the power of the Change Healthcare Platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient-engagement outcomes in the U.S. healthcare system.

Read More

FUTURE OF HEALTHCARE

Rockley Photonics and Medtronic Collaborate to Deliver the Next Generation of Wearable Healthcare Monitoring Devices

Rockley Photonics | March 11, 2022

Rockley Photonics Holdings Limited a global leader in photonics-based health monitoring and communications solutions, announced that it has agreed to enter a development partnership with Medtronic, a global leader in healthcare technology. The two companies plan to collaborate to bring Rockley’s recently announced Bioptx™ biomarker sensing platform into Medtronic’s solutions for use across various healthcare settings. Rockley’s biosensing technology is expected to expand the capabilities of wearable medtech devices by miniaturizing the measurement and analysis of a range of biomarkers into a compact form factor. These advances mean that a single wearable device could monitor multiple crucial biomarkers – including core body temperature, blood pressure, body hydration, alcohol, lactate, and glucose trends, among others. The Bioptx platform offers an end-to-end sensing solution that integrates cloud analytics and artificial intelligence (AI) to potentially deliver a holistic assessment of a variety of conditions. The partnership with Medtronic builds on the societal shift from reactive to proactive healthcare by potentially enabling round-the-clock, real-time, non-invasive monitoring of a person’s health and well-being, thereby empowering clinicians to personalize care with actionable data. “This partnership combines Medtronic’s exceptional strength in providing in-patient care with Rockley’s expertise in wearable, remote monitoring. I believe that this collaboration will bring to life our vision of giving people better insights into their health and well-being. We are excited about the potential for this partnership to herald the next generation of wearable devices and deliver a complete lifecycle of patient care.” Dr. Andrew Rickman, chairman and chief executive officer of Rockley About Rockley Photonics A global leader in photonics-based health monitoring and communications solutions, Rockley Photonics is developing a comprehensive range of photonic integrated circuits and associated modules, sensors, and full-stack solutions. From next-generation sensing platforms specifically designed for mobile health monitoring and machine vision to high-speed, high-volume solutions for data communications, Rockley is laying the foundation for a new generation of applications across multiple industries. Rockley believes that photonics will eventually become as pervasive as micro-electronics, and it has developed a platform with the power and flexibility needed to address both mass markets and a wide variety of vertical applications.

Read More

HEALTH TECHNOLOGY

Stryker, One of the World’s Leading Medical Technology Companies, announces definitive agreement to acquire Vocera Communications

Stryker | January 07, 2022

Strykerannounced today a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of Vocera Communications, Inc.for $79.25 per share, or a total equity value of approximately $2.97 billion and a total enterprise value of approximately $3.09 billion (including convertible notes). Vocera, which was founded in 2000, has emerged as a leading platform in the digital care coordination and communication category. The importance of this growing segment has continued to expand throughout the pandemic as it aims to reduce cognitive overload for caregivers and enables them to deliver the best patient care possible. Vocera brings a highly complementary and innovative portfolio to Stryker’s Medical division that will address the increasing need for hospitals to connect caregivers and disparate data-generating medical devices, which will help drive efficiencies and improve safety and outcomes. Vocera’s highly developed software competency, unique and innovative hardware solutions, and the ability to securely enable remote communication between patients and their families, complements Stryker's Advanced Digital Healthcare offerings. The combined business will further advance Stryker’s focus on preventing adverse events throughout the continuum of care. “This acquisition underscores our commitment and focus on our customer. Vocera will help Stryker significantly accelerate our digital aspirations to improve the lives of caregivers and patients.” Kevin Lobo, Chair and Chief Executive Officer, Stryker “Today’s milestone represents an exciting opportunity for Vocera given the clear alignment of mission, goals and culture between our two organizations and our ability to drive even greater economic and clinical value for our customers,” said Brent Lang, Chairman and Chief Executive Officer, Vocera. Under the terms of the merger agreement, Stryker will commence a tender offer for all outstanding shares of common stock of Vocera for $79.25 per share in cash. The boards of directors of both Stryker and Vocera have unanimously approved the transaction. The closing of the transaction is subject to expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, completion of the tender offer and other customary closing conditions. The acquisition is expected to close in the first quarter of 2022 and is expected to have a neutral impact to net earnings per diluted share in 2022. About Stryker Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. About Vocera The mission of Vocera Communications, Inc. is to improve the lives of healthcare professionals, patients, and families. Founded in 2000, Vocera provides clinical communication and workflow solutions that help protect and connect team members, increase operational efficiency, enhance quality of care and safety, and humanize the healthcare experience. More than 2,300 facilities worldwide, including nearly 1,900 hospitals and healthcare facilities, have selected Vocera solutions to enable their workforce to communicate and collaborate with co-workers and engage with patients and families. Mobile workers can choose the right device for their role or task, including smartphones or one of the company’s wearable communication devices, and use voice commands to easily reach people by name, role, or group. The hands-free Vocera Smartbadge was named to TIME’s list of the 100 Best Inventions of 2020. Vocera solutions can integrate with more than 150 clinical and operational systems, including electronic health records, nurse call systems, ventilators, physiological monitors, and more. In addition to healthcare, Vocera solutions are found in aged care facilities, veterinary hospitals, schools, luxury hotels, retail stores, power facilities, and more.

Read More

FUTURE OF HEALTHCARE

Gozio Health Announces Financial Partnership with Morgan Stanley Expansion Capital

Gozio Health | March 31, 2022

Gozio Health, an industry-leading location-aware mobile patient engagement platform, announced the closing of an investment from funds managed by Morgan Stanley Expansion Capital. The investment round will be used to accelerate Gozio's growth and sets the stage for a long-term financial partnership. “We are at a turning point in healthcare where digital strategy is not only a competitive differentiator for health systems but is foundational to positive consumer experiences. An effective digital platform can enhance engagement with patients, prevent revenue leakage and increase overall patient satisfaction. With the strong support of Morgan Stanley, Gozio is poised to substantially ramp up efforts to equip health systems with the kind of robust, extensible platform needed to optimize digital engagement.” Joshua Titus, Founder and CEO of Gozio Gozio’s mobile patient engagement solution provides health systems with a turnkey digital front door, offering a unified platform which integrates HCIT applications, including physician directories, appointment scheduling, EHR and patient record access, into an easy-to-use mobile application. Gozio’s solution also leverages the Company’s patented, industry-leading wayfinding technology to provide real-time, turn-by-turn directions to patients and staff. “The consumerization of healthcare is driving hospitals and health systems to increasingly focus on patient experience and engagement. Gozio offers a solution that helps patients not only navigate the physical network of the health system, but also provides patients mobile access to the services, information and applications necessary to engage patients in their own care,” said Melissa Daniels, Managing Director at Morgan Stanley Expansion Capital. “We believe Gozio’s digital front door and wayfinding technology provide a compelling value proposition by enhancing the personal end-to-end consumer experience within the network of the health system. We are thrilled to be partnering with Joshua and the Gozio team to support the Company as it continues on its growth trajectory.” Gozio will use the funding to expand its client base among leading health systems, grow its client services and engineering teams, and advance the extensibility of its platform to support a digital health ecosystem. About Gozio Health Gozio Health offers an end-to-end, customizable digital health platform exclusively for healthcare systems. Gozio’s extensible mobile platform enables seamless consumer interactions and provides an anytime, anywhere connection to patients that improves their overall experience and access to care. Popular patient engagement features include patented indoor wayfinding with turn-by-turn navigation, virtual visits, physician directories, appointment scheduling, access to electronic health records, Urgent Care and Emergency Department wait-times, and extensive analytics capabilities. Gozio customers surveyed in a 2021 KLAS Research Emerging Technology Spotlight report found 100% satisfaction and improved experience for patients and staff. About Morgan Stanley Expansion Capital Morgan Stanley Expansion Capital is the growth-focused private investment platform within Morgan Stanley Investment Management. Morgan Stanley Expansion Capital targets growth equity and credit investments within technology, healthcare, consumer, digital media and other high-growth sectors. For over three decades, Morgan Stanley Expansion Capital has successfully pursued growth investment opportunities and has completed investments in over 200 companies, leveraging the global brand and network of Morgan Stanley.

Read More

Spotlight

The pumps were run at 999 mL/hr until 50 mL were infused through each set. Then six more samples were collected from each unit and analyzed for plasma hemoglobin, total RBC count, hematocrit and mean corpuscular volume (MCV).

Resources